File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1016/j.vaccine.2008.08.016
- Scopus: eid_2-s2.0-55049122726
- PMID: 18761386
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: Impact of varicella vaccination on health care outcomes in Ontario, Canada: Effect of a publicly funded program?
Title | Impact of varicella vaccination on health care outcomes in Ontario, Canada: Effect of a publicly funded program? |
---|---|
Authors | |
Keywords | Health services utilization Publicly funded vaccination programs Varicella vaccines |
Issue Date | 2008 |
Citation | Vaccine, 2008, v. 26, n. 47, p. 6006-6012 How to Cite? |
Abstract | Varicella vaccines have been available for private purchase in Canada since 1998. Ontario introduced publicly funded varicella vaccination in 2004. We assessed the effects of private availability of varicella vaccines and subsequent implementation of a publicly funded vaccination program on varicella-related hospitalizations, emergency department (ED) use, and visits to physicians' offices in Ontario. Rates of hospitalizations, ED use, and office visits decreased 53% (95% CI, 48-58%), 43% (95% CI, 41-44%), and 45% (95% CI, 44-45%) after publicly funded vaccination, compared to only 9% (95% CI, 4-14%), 23% (95% CI, 22-24%), and 29% (95% CI, 28-29%) after private availability. Varicella vaccination is effective at reducing varicella-related health care use, with benefits extending beyond those who receive the vaccine. Publicly funded vaccination programs may be more effective than private vaccine availability. © 2008 Elsevier Ltd. All rights reserved. |
Persistent Identifier | http://hdl.handle.net/10722/346544 |
ISSN | 2023 Impact Factor: 4.5 2023 SCImago Journal Rankings: 1.342 |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kwong, Jeffrey C. | - |
dc.contributor.author | Tanuseputro, Peter | - |
dc.contributor.author | Zagorski, Brandon | - |
dc.contributor.author | Moineddin, Rahim | - |
dc.contributor.author | Chan, Kevin J. | - |
dc.date.accessioned | 2024-09-17T04:11:38Z | - |
dc.date.available | 2024-09-17T04:11:38Z | - |
dc.date.issued | 2008 | - |
dc.identifier.citation | Vaccine, 2008, v. 26, n. 47, p. 6006-6012 | - |
dc.identifier.issn | 0264-410X | - |
dc.identifier.uri | http://hdl.handle.net/10722/346544 | - |
dc.description.abstract | Varicella vaccines have been available for private purchase in Canada since 1998. Ontario introduced publicly funded varicella vaccination in 2004. We assessed the effects of private availability of varicella vaccines and subsequent implementation of a publicly funded vaccination program on varicella-related hospitalizations, emergency department (ED) use, and visits to physicians' offices in Ontario. Rates of hospitalizations, ED use, and office visits decreased 53% (95% CI, 48-58%), 43% (95% CI, 41-44%), and 45% (95% CI, 44-45%) after publicly funded vaccination, compared to only 9% (95% CI, 4-14%), 23% (95% CI, 22-24%), and 29% (95% CI, 28-29%) after private availability. Varicella vaccination is effective at reducing varicella-related health care use, with benefits extending beyond those who receive the vaccine. Publicly funded vaccination programs may be more effective than private vaccine availability. © 2008 Elsevier Ltd. All rights reserved. | - |
dc.language | eng | - |
dc.relation.ispartof | Vaccine | - |
dc.subject | Health services utilization | - |
dc.subject | Publicly funded vaccination programs | - |
dc.subject | Varicella vaccines | - |
dc.title | Impact of varicella vaccination on health care outcomes in Ontario, Canada: Effect of a publicly funded program? | - |
dc.type | Article | - |
dc.description.nature | link_to_subscribed_fulltext | - |
dc.identifier.doi | 10.1016/j.vaccine.2008.08.016 | - |
dc.identifier.pmid | 18761386 | - |
dc.identifier.scopus | eid_2-s2.0-55049122726 | - |
dc.identifier.volume | 26 | - |
dc.identifier.issue | 47 | - |
dc.identifier.spage | 6006 | - |
dc.identifier.epage | 6012 | - |